Use access key #2 to skip to page content.
$4.80 -0.03 (-0.62%)
7/3/2008 1:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View Ticker Page (EXEL)

Results 11 - 20 of 350 :   12345Next »

Recs

8

Avatar ari21 (95.05) Submitted: 9/24/06 3:22 PM : Outperform Start Price: $8.99 EXEL Score: -42.49

this is a risky stock. Biotec company. Their drug pipeline, and the quality of the partnerships increases their chances to be a winning company in that risky sector.Only invest a small percent of your portfolio. Even with the positive resullts they g...

Report this Post Replies: 0 | Reply | Permalink

Recs

6

Avatar TMFBreakerDave (98.66) Submitted: 5/26/06 2:18 PM : Outperform Start Price: $10.22 EXEL Score: -51.62

See Charly Travers's work at our Motley Fool Rule Breakers service. There's a lot more there about Exelexis's cancer drugs and their advantages over what exists today.

Report this Post Replies: 0 | Reply | Permalink

Recs

6

Avatar PDTBiotech (44.11) Submitted: 5/08/08 1:58 AM : Outperform Start Price: $6.90 EXEL Score: -20.79

Exelixis (EXEL) develops drugs for the treatment of cancer and other proliferative diseases. I had been looking for a decent entry point, and today's 11.65% drop on their earnings release looks like a decent one. The drop is most likely due to the ...

Report this Post Replies: 0 | Reply | Permalink

Recs

5

Avatar Budsworth (47.47) Submitted: 6/06/08 5:59 AM : Outperform Start Price: $6.40 EXEL Score: -14.96

The acquisition of $150M is great news. I've been eyeing this Bio for a while. this should give them the booster they needed to really show their true potential. If you really want to see what they are up to, look them up at www.exelixis.com The amou...

Report this Post Replies: 0 | Reply | Permalink

Recs

5

Avatar groundwaterguru (81.56) Submitted: 5/20/08 11:40 PM : Underperform Start Price: $6.63 EXEL Score: 16.07

A biotechnology company with no earnings is common, nothing new there. A few compounds are in the pipeline, nothing new there either. Buying this stock without insider knowledge is more akin to gambling than investing unless you have a statisticall...

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar cunnin7003 (79.27) Submitted: 9/29/06 5:16 PM : Outperform Start Price: $9.00 EXEL Score: -41.12

I've owned this stock for a while, haven't seen any upside yet, but it's coming... someday... Will try to add to my position over time, because in 10 years this could make us all rich.

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar Gatsby01 (59.38) Submitted: 3/02/08 10:05 PM : Outperform Start Price: $6.62 EXEL Score: -22.36

This pick is definitely outside my comfort zone. I feel like I am betting on my golf game ( which is not that good) but I have bought a few mulligans to improve the odds. Thanks to the Fool for bringing it to my attention and explaiing the rational...

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar stockreader (20.51) Submitted: 2/06/08 5:42 PM : Outperform Start Price: $7.41 EXEL Score: -28.41

Exelixis Inc. is probably the best place to be, when investing in biotechnology. I usually don't put my money in "hot" sectors, but this time I'm willing to make an exception because of the remarkable reputation this company enjoys. Recent price drop...

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar HelicalZz (98.65) Submitted: 12/20/06 5:42 PM : Outperform Start Price: $9.53 EXEL Score: -38.25

I'm not one to venture into drug companies on promise. I still think the best time to invest is after it has an approval and cash coming in (when pushed, I'd say wait for the 3rd drug approval). Still, I can't help but be impressed with Exelixis. ...

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar predfern (< 20) Submitted: 2/01/07 12:03 AM : Outperform Start Price: $9.80 EXEL Score: -38.64

Eleven drug candidates that are either in clinical testing or about to begin it. This magnitude of clinical development is unmatched for a biotech the size of Exelixis. Partnerships with many of the leading pharmaceutical and biotech companies.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners